Showing results (51-60 of 109) with videos related to
Sort By:
Pageof 11
Frontiers in Psychiatry|January 10, 2019
Implementation of a Quit Smoking Programme in Community Adult Mental Health Services-A Qualitative StudyAnnette Burns, Margaret Webb, Greg Stynes, et al.Chemical Communications (Cambridge, England)|July 2, 2025
Organometallic and zeolitic ultralight MOFs from lithium alkynyl building blocksRuichen Zhang, Tom O'Brien, Fauzi Abdilah, et al.Human Molecular Genetics|October 6, 2005
ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunctionGuiqing Huang, Sheryl Krig, David Kowbel, et al.Plos One|June 19, 2018
A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLCNicholas Dompe, Christiaan Klijn, Sara A Watson, et al.Science Signaling|January 30, 2009
EGFR signals to mTOR through PKC and independently of Akt in gliomaQi-Wen Fan, Christine Cheng, Zachary A Knight, et al.Cancer Research|October 3, 2008
PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformationKatsutoshi Oda, Jennifer Okada, Luika Timmerman, et al.Cell Cycle (Georgetown, Tex.)|June 28, 2008
Cell cycle-dependent phosphorylation of human CDC5 regulates RNA processingRemo Gräub, Hope Lancero, Anissa Pedersen, et al.Journal of Neuro-Oncology|September 2, 2008
Signal transduction molecules in gliomas of all gradesRalph P Ermoian, Tania Kaprealian, Kathleen R Lamborn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survivalRalph P Ermoian, Constance S Furniss, Kathleen R Lamborn, et al.Molecular Cancer Therapeutics|April 17, 2008
Characterization of structurally distinct, isoform-selective phosphoinositide 3'-kinase inhibitors in combination with radiation in the treatment of glioblastomaJack S Chen, Linda J Zhou, Michal Entin-Meer, et al.Pageof 11